Taking a Closer Look - Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients with Type 2 Diabetes Mellitus Under Basal-Bolus Insulin Therapy

Diabetes Technology and Therapeutics

Volumn 17, Issue 9, 2015, Pages 611-618

  Schaupp, Lukas ^a   Donsa, Klaus ^b   Neubauer, Katharina M ^a   Mader, Julia K ^a   Aberer, Felix ^a   Höll, Bernhard ^b   Spat, Stephan ^b   Augustin, Thomas ^b   Beck, Peter ^b   Pieber, Thomas R ^a,b   Plank, Johannes ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b JOANNEUM RESEARCH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; HEMOGLOBIN A1C PROTEIN, HUMAN;

AGED; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; BODY MASS; CONTINUOUS BLOOD GLUCOSE MONITORING; CREATININE BLOOD LEVEL; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ALGORITHM; ANALYSIS; BLOOD; CHEMICALLY INDUCED; CLINICAL TRIAL; DEVICES; DIABETES MELLITUS, TYPE 2; HOSPITALIZATION; MIDDLE AGED; PROCEDURES; REPRODUCIBILITY;

AGED; ALGORITHMS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALIZATION; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS;

EID: 84940662278     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0343     Document Type: Article

References (32)

1. Moghissi ES, Korytkowski MT, DiNardo M, et al.: American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009;32:1119-1131.
2. McAlister FA, Majumdar SR, Blitz S, et al.: The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 2005;28:810-815.
3. Swanson CM, Potter DJ, Kongable GL, et al.: Update on inpatient glycemic control in hospitals in the United States. Endocr Pract 2011;17:853-861.
4. Umpierrez GE, Hellman R, Korytkowski MT, et al.: Management of hyperglycemia in hospitalized patients in noncritical care setting: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2012;97:16-38.
5. Murad MH, Coburn JA, Coto-Yglesias F, et al.: Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis. J Clin Endocrinol Metab 2012;97:49-58.
6. Rayman G, National Health Service: National Diabetes Inpatient Audit 2012. 2013. www.hscic.gov.uk/catalogue/PUB10506/nati-diab-inp-audi-12-nat-rep.pdf (accessed April 20, 2015).
7. Draznin B, Gilden J, Golden SH, et al.: Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care 2013;36:1807-1814.
8. American Diabetes Association: Standards of medical care in diabetes - 2014. Diabetes Care 2014;37(Suppl 1):S14-S80.
9. Umpierrez GE, Smiley D, Zisman A, et al.: Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 2007;30:2181-2186.
10. Umpierrez GE, Smiley D, Hermayer K, et al.: Randomized study comparing a basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: Basal Plus Trial. Diabetes Care 2013;36:2169-2174.
11. Mader JK, Neubauer KM, Schaupp L, et al.: Efficacy, usability and sequence of operations of a workflow-integrated algorithm for basal-bolus insulin therapy in hospitalized type 2 diabetes patients. Diabetes Obes Metab 2014;16: 137-146.
12. Joseph JI, Hipszer B, Mraovic B, et al.: Clinical need for continuous glucose monitoring in the hospital. J Diabetes Sci Technol 2009;3:1309-1318.
13. Thabit H, Hovorka R: Glucose control in non-critically ill inpatients with diabetes: towards closed-loop. Diabetes Obes Metab 2014;16:500-509.
14. Gomez AM, Umpierrez GE: Continuous glucose monitoring in insulin-treated patients in non-ICU settings. J Diabetes Sci Technol 2014;8:930-936.
15. Boom DT, Sechterberger MK, Rijkenberg S, et al.: Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial. Crit Care 2014;18:453.
16. Beck RW, Calhoun P, Kollman C: Use of continuous glucose monitoring as an outcome measure in clinical trials. Diabetes Technol Ther 2012;14:877-882.
17. Bergenstal RM, Ahmann AJ, Bailey T, et al.: Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther 2013;15:198-211.
18. Clarke WL, Cox D, Gonder-Frederick LA, et al.: Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10:622-628.
19. Zijlstra E, Heise T, Nosek L, et al.: Continuous glucose monitoring: quality of hypoglycaemia detection. Diabetes Obes Metab 2013;15:130-135.
20. R Development Core Team: R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing, 2011.
21. Dungan KM, Osei K, Sagrilla C, et al.: Effect of the approach to insulin therapy on glycaemic fluctuations and autonomic tone in hospitalized patients with diabetes. Diabetes Obes Metab 2013;15:558-563.
22. Mendez CE, Mok K-T, Ata A, et al.: Increased glycemic variability is independently associated with length of stay and mortality in non-critically ill hospitalized patients. Diabetes Care 2013;36:4091-4097.
23. Inchiostro S, Candido R, Cavalot F: How can we monitor glycaemic variability in the clinical setting? Diabetes Obes Metab 2013;15(Suppl 2):13-16.
24. McGowan K, Thomas W, Moran A: Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 2002;25:1499-1503.
25. Cook CB, Wellik KE, Kongable GL, et al.: Assessing inpatient glycemic control: what are the next steps? J Diabetes Sci Technol 2012;6:421-427.
26. Unger J: Uncovering undetected hypoglycemic events. Diabetes Metab Syndr Obes 2012;5:57-74.
27. Jones GC, Casey H, Perry CG, et al.: Trends in recorded capillary blood glucose and hypoglycaemia in hospitalised patients with diabetes. Diabetes Res Clin Pract 2014;104:79-83.
28. Poolsup N, Suksomboon N, Kyaw AM: Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes. Diabetol Metab Syndr 2013;5:39.
29. Calhoun P, Lum J, Beck RW, et al.: Performance comparison of the Medtronic Sof-Sensor and Enlite glucose sensors in inpatient studies of individuals with type 1 diabetes. Diabetes Technol Ther 2013;15:758-761.
30. Rodbard D: Standardization versus customization of glucose reporting. Diabetes Technol Ther 2013;15:439-443.
31. Rodbard D: Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther 2009;11(Suppl 1):S-55-S-67.
32. Klonoff DC, Buckingham B, Christiansen JS, et al.: Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011;96: 2968-2979.